Genmab | GEN - Operating Expenses

Stock Price
2,097.00
Daily Change
7.00 0.33%
Monthly
4.33%
Yearly
51.08%
Q1 Forecast
1,920.90

Genmab reported DKK565M in Operating Expenses for its fiscal quarter ending in June of 2025.





Operating Expenses Change Date
Agios Pharmaceuticals USD 129.75M 9.76M Sep/2025
Almirall EUR 517.43M 43.18M Jun/2025
Amarin USD 51.37M 14.6M Sep/2025
Amgen USD 5.13B 1.39B Sep/2025
argenx SE USD 776.99M 32.87M Sep/2025
AstraZeneca USD 16.69B 5.74B Sep/2025
Bayer EUR 10.2B 523M Sep/2025
BioMarin Pharmaceutical USD 807.82M 259.3M Sep/2025
Demant DKK 9.39B 392M Jun/2025
Exelixis USD 341.4M 13.29M Sep/2025
Fresenius Medical Care EUR 4.43B 73.91M Sep/2025
Galapagos EUR 112.83M 9.48M Sep/2025
Genmab DKK 565M 38M Jun/2025
GlaxoSmithKline GBP 5.76B 203M Sep/2025
GN Store Nord DKK 3.62B 81M Sep/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Insmed USD 403.69M 42.4M Sep/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
UCB EUR 2.36B 108M Dec/2024